PMC:7311890 / 16459-16815
Annnotations
LitCovid-PD-MONDO
Id | Subject | Object | Predicate | Lexical cue | mondo_id |
---|---|---|---|---|---|
T95 | 173-181 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
LitCovid-PD-CLO
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T150 | 83-87 | http://purl.obolibrary.org/obo/CLO_0054057 | denotes | 18:1 |
T151 | 138-142 | http://purl.obolibrary.org/obo/CLO_0054057 | denotes | 18:1 |
T152 | 231-233 | http://purl.obolibrary.org/obo/CLO_0001382 | denotes | 48 |
T153 | 236-238 | http://purl.obolibrary.org/obo/CLO_0050510 | denotes | 18 |
T154 | 276-280 | http://purl.obolibrary.org/obo/CLO_0054057 | denotes | 18:1 |
T155 | 304-306 | http://purl.obolibrary.org/obo/CLO_0001302 | denotes | 34 |
T156 | 314-316 | http://purl.obolibrary.org/obo/CLO_0050510 | denotes | 18 |
LitCovid-PD-CHEBI
Id | Subject | Object | Predicate | Lexical cue | chebi_id |
---|---|---|---|---|---|
T140 | 7-13 | Chemical | denotes | lipids | http://purl.obolibrary.org/obo/CHEBI_18059 |
T141 | 55-76 | Chemical | denotes | lysophosphatidic acid | http://purl.obolibrary.org/obo/CHEBI_132742|http://purl.obolibrary.org/obo/CHEBI_16975 |
T143 | 72-76 | Chemical | denotes | acid | http://purl.obolibrary.org/obo/CHEBI_37527 |
T144 | 78-81 | Chemical | denotes | LPA | http://purl.obolibrary.org/obo/CHEBI_132742 |
T145 | 105-128 | Chemical | denotes | lysophosphatidylcholine | http://purl.obolibrary.org/obo/CHEBI_60479 |
T146 | 130-136 | Chemical | denotes | LysoPC | http://purl.obolibrary.org/obo/CHEBI_60479 |
T147 | 197-203 | Chemical | denotes | lipids | http://purl.obolibrary.org/obo/CHEBI_18059 |
T148 | 227-235 | Chemical | denotes | TAG 48:1 | http://purl.obolibrary.org/obo/CHEBI_85726 |
T149 | 236-240 | Chemical | denotes | 18:0 | http://purl.obolibrary.org/obo/CHEBI_28842 |
T150 | 267-275 | Chemical | denotes | TAG 60:3 | http://purl.obolibrary.org/obo/CHEBI_132039 |
T151 | 300-308 | Chemical | denotes | DAG 34:1 | http://purl.obolibrary.org/obo/CHEBI_85694 |
T152 | 309-313 | Chemical | denotes | 16:1 | http://purl.obolibrary.org/obo/CHEBI_24548 |
T153 | 314-318 | Chemical | denotes | 18:0 | http://purl.obolibrary.org/obo/CHEBI_28842 |
LitCovid-PubTator
Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
---|---|---|---|---|---|
485 | 173-181 | Disease | denotes | COVID-19 | MESH:C000657245 |
LitCovid-sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T118 | 0-356 | Sentence | denotes | As for lipids, increases in lysophopholipids including lysophosphatidic acid (LPA) 18:1 (p = 0.0249) and lysophosphatidylcholine (LysoPC) 18:1 (p = 0.0350) were observed in COVID-19, while neutral lipids including medium-chain TAG 48:1(18:0) (p = 0.0190), long-chain TAG 60:3(18:1) (p = 0.0390), and DAG 34:1(16:1/18:0) (p = 0.0010) were generally reduced. |
LitCovid-PMC-OGER-BB
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T344 | 7-13 | CHEBI:18059;CHEBI:18059 | denotes | lipids |
T345 | 28-44 | CHEBI:18303;CHEBI:18303 | denotes | lysophopholipids |
T346 | 55-76 | CHEBI:32957;CHEBI:32957 | denotes | lysophosphatidic acid |
T347 | 78-81 | CHEBI:16412;CHEBI:16412 | denotes | LPA |
T348 | 105-128 | CHEBI:60479;CHEBI:60479 | denotes | lysophosphatidylcholine |
T349 | 173-181 | SP_7 | denotes | COVID-19 |
T350 | 197-203 | CHEBI:18059;CHEBI:18059 | denotes | lipids |
T351 | 214-226 | CHEBI:61907;CHEBI:61907 | denotes | medium-chain |
T352 | 227-230 | CHEBI:17855;CHEBI:17855 | denotes | TAG |
T353 | 256-266 | CHEBI:15904;CHEBI:15904 | denotes | long-chain |
T354 | 267-270 | CHEBI:17855;CHEBI:17855 | denotes | TAG |
T355 | 300-303 | CHEBI:42098;CHEBI:42098 | denotes | DAG |
T96461 | 51-61 | CL:0000542 | denotes | ing lysoph |
T31068 | 128-141 | CL:0000084 | denotes | (LysoPC) 18: |
T39989 | 146-149 | PR:000001004 | denotes | = 0 |
T98816 | 151-164 | CL:0000084 | denotes | 350) were obs |
T45288 | 307-315 | SP_7 | denotes | 1(16:1/1 |